Zotarolimus with Durable Polymer vs. Biolimus with Biodegradable Polymer

Zotarolimus with Durable Polymer vs. Biolimus with Biodegradable PolymerThe present work compared the safety and efficacy of the permanent polymer zotarolimus eluting stent vs. the biodegradable polymer biolimus eluting stent in unselected coronary artery disease patients.

 

The biodegradable polymer biolimus eluting stent resulted superior to the first generation durable polymer stent in long term randomized studies.  However, little evidence supports this superiority when compared to the current durable polymer DES.

 

The study was randomized, multicenter and with no inferiority design in patients with stable coronary artery disease, acute coronary syndromes and, at least, one coronary lesion requiring stent implantation. End points included a combination of major adverse cardiac events (cardiac death and acute myocardial infarction). In addition, end point individual components were analyzed separately, including probable or definite thrombosis at 36 months.

 

Between March 2011 and August 2012, the study enrolled 2999 patients randomized 1:1 to receiving the zotarolimus eluting stent (1502 patients) vs. the biolimus eluting stent (1497 patients).

 

At three year follow up, combined events (MACE) occurred in 128 patients (8.6%) of those receiving the durable polymer stent vs. 144 patients (9.6%) of those receiving the biodegradable polymer stents (p=0.36).

 

Cardiac death (2.7% vs. 3.4%), acute myocardial infarction (2.7% vs 2.5%) and lesion revascularization (5.4% vs. 5.5%) did not significantly differ between both groups.

 

Neither did very late definite thrombosis, with 0.4% for the durable polymer and 0.7% for the biodegradable polymer (p=0.33).

 

Conclusion

At three years, the durable polymer zotarolimus eluting stent and the degradable polymer biolimus eluting stent saw similar adverse events rates and saw non-significant differences in safety and efficacy, including definite thrombosis.

 

Original Title: Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease. 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.

Reference: Raungaard B et al. JACC Cardiovasc Interv. 2017 Feb 13;10(3):255-264.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

FLAVOUR Trial Substudy: FFR or IVUS in the Assessment of Diabetic Patients

Patients with diabetes often present with more complex coronary artery disease compared to non-diabetic patients, with a higher prevalence of diffuse or multivessel disease....

Mechanical Circulatory Support in Complex Anatomies and Severe Deterioration of Left Ventricular Function

Severe coronary artery disease (CAD) frequently causes left ventricular function deterioration, and is often treated with myocardial revascularization surgery (CABG), especially when ejection fraction...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...